Question 45

Federal law may require a Medication Guide to be distributed to patients as part of a Risk Evaluation and Mitigation Strategy (REMS).

Medication Guides are specifically mandated under Risk Evaluation and Mitigation Strategies (REMS) to ensure that patients receive critical information about the risks associated with certain medications.

A) adverse drug event (ADE)

Adverse drug events (ADEs) refer to harmful effects resulting from medication use, but they do not inherently require the distribution of Medication Guides. While ADEs may indicate a need for better patient information, they are not the strategic framework under which Medication Guides are issued.

B) Risk Evaluation and Mitigation Strategy (REMS)

Risk Evaluation and Mitigation Strategies (REMS) are programs mandated by the FDA to ensure that the benefits of a drug outweigh its risks. Part of these strategies often includes the requirement for Medication Guides to be provided to patients, making this option correct. REMS are specifically designed to manage the risks associated with certain medications and to enhance patient safety.

C) Safety Data Sheet (SDS)

Safety Data Sheets (SDS) are documents that provide information about the properties of a particular substance, including handling, hazards, and emergency measures. While important for safety in workplaces, they are not related to patient medication information and do not require the distribution of Medication Guides.

D) FDA class I recall

An FDA class I recall indicates a situation where there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. While recalls may prompt communication to patients, they do not systematically involve the distribution of Medication Guides as part of a regulatory requirement.

Conclusion

Risk Evaluation and Mitigation Strategies (REMS) are the specific framework through which Medication Guides are required to be distributed, ensuring that patients receive essential safety information about certain medications. Other options, such as adverse drug events, Safety Data Sheets, and FDA recalls, do not involve the systematic distribution of Medication Guides and therefore do not meet the criteria established by federal law for this requirement.